Book Prostate Cancer Genetic Test | Lahalak Medical Platform

Protect your health future with early detection of hereditary prostate cancer predisposition. This advanced genetic test accurately identifies your genetic risks, allowing for proactive preventive steps and ensuring a safer life.

Scientific name: Germline Genetic Testing for Prostate Cancer (BRCA1/2, HOXB13)

An advanced laboratory test screening for genetic mutations like BRCA1, BRCA2, and HOXB13 linked to aggressive prostate cancer. It assesses hereditary risks to guide personalized early detection programs for men.

Germline Genetic Testing for Prostate Cancer (BRCA1/2, HOXB13) - Genetic Risk Assessment for Prostate Cancer
Service type Laboratory test
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Blood sample collection
  • Genetic mutation analysis (BRCA1/2, HOXB13)
  • Detailed result report

Medical Service Information

Purpose of Genetic Screening

  • Identify hereditary predisposition to aggressive prostate cancer.
  • Assist doctors in creating intensive early screening plans for high-risk individuals.
  • Provide critical information for family members regarding shared genetic risks.

Who Should Get Tested?

  • Men with a strong family history of prostate, breast, or ovarian cancer.
  • Men already diagnosed with prostate cancer to assess disease aggressiveness.
  • Men over 40 seeking a precise assessment of their health risks.

Significance of BRCA & HOXB13 Genes

  • BRCA1 and BRCA2 mutations increase the likelihood of more severe cancer types.
  • The HOXB13 gene is strongly linked to early-onset hereditary prostate cancer.
  • Knowing these mutations helps in selecting targeted therapies if cancer occurs.

Conditions & Notices

  • Family medical history is preferred
  • Test is not affected by routine medications

Medical services you might also like